Vitamin D and diabetes: Much ado about nothing?;Vitamine D et diabète: beaucoup de bruit pour rien ?

Diabetes and Metabolism

Volumn 36, Issue 5, 2010, Pages 323-325

  Monnier, L ^a   Colette, C ^a  

^a University Institute of Clinical Research   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; INSULIN; VITAMIN D;

CONTINUOUS INFUSION; DIETARY INTAKE; EDITORIAL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL STATUS; RISK FACTOR; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION;

DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; HUMANS; INSULIN; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 78649448512     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2010.06.003     Document Type: Editorial

References (26)

1. Colette C., Pares-Herbute N., Monnier L., Selam J.L., Thomas N., Mirouze J. Effect of different insulin administration modalities on vitamin D metabolism of insulin-dependent diabetic patients. Horm Metab Res 1989, 21:37-41.
2. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004, 80 Suppl.:1689S-1696S.
3. Heaney R.P. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr 2004, 80 Suppl.:1706S-1709S.
4. Bischoff-Ferrari H.A., Giovannuci E., Willett W.C., Dietrich T., Dawson-Hugues B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006, 84:18-28.
5. Hollis B.W. Measuring 25-hydroxyvitamin D in a clinical environment: challenges and needs. Am J Clin Nutr 2008, 88 Suppl.:507S-510S.
6. The EURODIAB Substudy 2 Study Group Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus. Diabetologia 1999, 42:51-54.
7. Hyppönen E., Läärä E., Reunanen Z., Järvelin M.J., Virtanen S.M. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001, 358:1500-1503.
8. Mathieu C., Gysemans C., Giuletti A., Bouillon R. Vitamin D and diabetes. Diabetologia 2005, 48:1247-1257.
9. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
10. Norman A.W. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 2008, 88 Suppl.:491S-499S.
11. Baz-Hecht M., Goldfine A.B. The impact of vitamin D deficiency on diabetes and cardiovascular risk. Curr Opin Endocrinol Diabetes Obes 2010, 7:113-119.
12. Hyppönen E., Power C. Hypovitaminosis D. British adults at age 45 y: nationwide cohort study of dietary and life predictors. Am J Clin Nutr 2007, 85:860-868.
13. Littorin B., Blom P., Schölin A., Arnqvist H.J., Blohmé G., Bolinder J., et al. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 2006, 49:2847-2852.
14. Isaia G., Giorgino R., Adami S. High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care 2001, 24:1496.
15. Mattila C., Knekt P., Männistö S., Rissanen H., Laaksonen M.A., Montonen J., et al. Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 2007, 30:2569-2570.
16. Cantorna M.T., Zhu Y., Froicu M., Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3 and the immune system. Am J Clin Nutr 2004, 80 Suppl.:1717S-1720S.
17. Penna G., Roncari A., Armuchastegui S., Daniel K.C., Berti E., Colonna M., et al. Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4 + Foxp 3 + regulatory T cells by 1,25-hydroxyvitamin D3. Blood 2005, 106:3490-3497.
18. Bell N.H., Epstein S., Greene A., Shary J., Oexmann M.J., Shaw S. Evidence for alteration of the vitamin D endocrine system in obese subjects. J Clin Invest 1985, 76:370-373.
19. Wortsman J., Matsuoka L.Y., Chen T.C., Lu Z., Holick M.F. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000, 72:690-693.
20. Borissova A.M., Tankova T., Kirilov G., Dakovska L., Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 2003, 57:258-261.
21. Taylor A.V., Wise P.H. Vitamin D replacement in Asian with diabetes may increase insulin resistance. Postgrad Med J 1998, 74:365-366.
22. Snijder M., Van Dam R., Visser M., Deeg D., Seidell J., Lips P. Letter-comment to: Mathieu C, Gysemans C, Giuletti A. Bouillon R (2005). Vitamin D and diabetes. Diabetologia 2005;48:1247-57. Diabetologia 2006, 49:217-218.
23. Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 2008, 88 Suppl.:582S-586S.
24. Hathcock J.N., Shao A., Vieth R., Heaney R. Risk assessment for vitamin D. Am J Clin Nutr 2007, 85:6-18.
25. Hayes D.P. Adverse effects of nutritional inadequacy and excess: a hormetic model. Am J Clin Nutr 2008, 88 Suppl.:578S-581S.
26. Vieth R., Bischoff-Ferrari H., Boucher B.J., Dawson-Hugues B., Garland C.F., Heaney R.P., et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 2007, 85:649-650.